CX-2029 is the first CD71-targeting antibody-drug conjugate (ADC) administrated to patients, with a generally well-tolerated safety profile at doses that...
New Phase I clinical trial, called INSIGHT-003, in patients with various solid tumoursExpands the evaluation of efti into a triple...
Garner location becomes CarolinasDentist’s 10th office in North CarolinaGARNER, N.C., June 21, 2021 (GLOBE NEWSWIRE) -- CarolinasDentist, a local dental...
Presentation Scheduled for June 24, 2021 at 11:30 a.m., EDTCHARLOTTESVILLE, Va., June 21, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc....
EMERYVILLE, Calif., June 21, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced its Board...
– Analysis of final Day 29 data from COMET-ICE confirms sotrovimab significantly reduces hospitalization and risk of death in adults with...
NEW YORK, June 21, 2021 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline...
CAMBRIDGE, Mass., June 21, 2021 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the field of cellular...
Industry Leading Developer of Solventless Extraction Technology and Products Discuss Their Continued Commitment Empowering the Development of High-Quality Safe Extracts...
Long COVID Symptoms of Pain, Sleep Disturbance, Fatigue and Brain Fog Overlap with Symptoms of Fibromyalgia, for which TNX-102 SL...
Picture 1 Phase 2: Improvement in All Key Domains Picture 2 Favorable Efficacy Already at Low ANAVEX®2-73 Doses Picture 3...
PRINCETON, N.J., June 21, 2021 (GLOBE NEWSWIRE) -- Oyster Point Pharma, Inc. (Nasdaq: OYST), a clinical-stage biopharmaceutical company focused on...
SOUTH SAN FRANCISCO, Calif., June 21, 2021 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals, a clinical-stage biopharmaceutical company dedicated to developing...
MediPharm Labs’ Cannabis Drug Licence and expertise qualifies and positions the Company to supply clinical trial material, assist in investigation...
– Fulcrum to host conference call on June 24, 2021 at 8:00am ET to present results from Phase 2b ReDUX4...
Request for Pre-Investigator New Drug Meeting to Be Submitted to FDA in Near TermLOS ANGELES, June 21, 2021 (GLOBE NEWSWIRE)...
TORONTO, June 21, 2021 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”), a...
ZHUHAI, China, June 21, 2021 (GLOBE NEWSWIRE) -- Jafron Biomedical, a pioneer in the blood purification industry, announced it's founding...
Vancouver, British Columbia--(Newsfile Corp. - June 21, 2021) - Genix Pharmaceuticals Corporation (TSXV: GENX) (OTCQB: GENPF) ("GENIX" or the "Company)...
Jackson Center, Pennsylvania--(Newsfile Corp. - June 21, 2021) - Halberd Corporation's (OTC Pink: HALB) proprietary technology enters stage 4 to...